Voya Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Buy
8,572
+272
+3% +$89.4K 0.24% 40
2025
Q4
$2.89M Sell
8,300
-576
-6% -$195K 0.28% 36
2025
Q3
$2.84M Sell
8,876
-185
-2% -$57.5K 0.27% 35
2025
Q2
$3.46M Sell
9,061
-97
-1% -$39K 0.35% 28
2025
Q1
$3.96M Buy
9,158
+563
+7% +$226K 0.44% 22
2024
Q4
$3.17M Buy
8,595
+1,832
+27% +$767K 0.34% 28
2024
Q3
$3.54M Buy
6,763
+72
+1% +$38.5K 0.38% 23
2024
Q2
$3.58M Buy
6,691
+461
+7% +$244K 0.41% 21
2024
Q1
$3.24M Buy
6,230
+603
+11% +$300K 0.37% 22
2023
Q4
$2.64M Sell
5,627
-422
-7% -$195K 0.32% 24
2023
Q3
$2.71M Buy
6,049
+1,096
+22% +$497K 0.34% 18
2023
Q2
$2.18M Buy
4,953
+327
+7% +$151K 0.25% 28
2023
Q1
$2.12M Sell
4,626
-94
-2% -$44.7K 0.26% 24
2022
Q4
$2.42M Sell
4,720
-630
-12% -$320K 0.31% 26
2022
Q3
$2.44M Buy
5,350
+142
+3% +$67.9K 0.32% 26
2022
Q2
$2.53M Buy
5,208
+352
+7% +$174K 0.31% 31
2022
Q1
$2.44M Buy
4,856
+1,275
+36% +$583K 0.28% 32
2021
Q4
$1.67M Buy
3,581
+280
+8% +$118K 0.19% 53
2021
Q3
$1.28M Buy
3,301
+129
+4% +$49K 0.16% 68
2021
Q2
$1.21M Sell
3,172
-14,711
-82% -$5.62M 0.16% 69
2021
Q1
$6.51M Buy
17,883
+635
+4% +$204K 0.26% 61
2020
Q4
$5.42M Sell
17,248
-1,073
-6% -$329K 0.23% 67
2020
Q3
$4.76M Buy
18,321
+544
+3% +$146K 0.24% 67
2020
Q2
$4.61M Buy
17,777
+1,108
+7% +$296K 0.24% 71
2020
Q1
$3.84M Buy
16,669
+996
+6% +$271K 0.21% 77
2019
Q4
$4.79M Buy
15,673
+282
+2% +$77.6K 0.24% 79
2019
Q3
$3.66M Buy
15,391
+1,073
+7% +$294K 0.2% 91
2019
Q2
$4.04M Buy
14,318
+5,551
+63% +$1.52M 0.22% 87
2019
Q1
$2.48M Buy
8,767
+1,049
+14% +$303K 0.14% 122
2018
Q4
$2M Buy
7,718
+426
+6% +$117K 0.13% 133
2018
Q3
$1.98M Buy
7,292
+479
+7% +$124K 0.12% 147
2018
Q2
$1.63M Buy
6,813
+613
+10% +$142K 0.11% 165
2018
Q1
$1.37M Buy
6,200
+4,635
+296% +$1.09M 0.09% 187
2017
Q4
$355K Buy
1,565
+16
+1% +$3.41K 0.02% 388
2017
Q3
$294K Sell
1,549
-59
-4% -$11.2K 0.02% 410
2017
Q2
$301K Sell
1,608
-48
-3% -$8.63K 0.02% 395
2017
Q1
$273K Buy
1,656
+66
+4% +$10.5K 0.02% 402
2016
Q4
$230K Buy
+1,590
New +$213K 0.02% 409
2016
Q3
Sell
-1,737
Closed -$228K 435
2016
Q2
$228K Buy
1,737
+151
+10% +$20.7K 0.03% 362
2016
Q1
$222K Sell
1,586
-206
-11% -$27.5K 0.03% 340
2015
Q4
$253K Buy
1,792
+56
+3% +$7.71K 0.04% 285
2015
Q3
$239K Buy
1,736
+6
+0.3% +$902 0.04% 267
2015
Q2
$282K Buy
+1,730
New +$276K 0.05% 244

Other funds holding ELV

Voya Financial Advisors's ELV Position: Q1 2026 in Review

Voya Financial Advisors increased its Elevance Health (ELV) stake by 3.3% in Q1 2026, buying an estimated $89.4K and bringing the position to 8,572 shares worth $2.45M. The position accounts for 0.24% of the portfolio, ranked #40.

Voya Financial Advisors first reported a position in ELV in Q2 2015 and has held it in 43 quarters since. The position peaked at $6.51M in Q1 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Voya Financial Advisors held 8,572 shares of Elevance Health worth $2.45M as of Q1 2026.
  • Voya Financial Advisors bought 272 Elevance Health shares in Q1 2026, an estimated $89.4K.
  • Elevance Health made up 0.24% of Voya Financial Advisors's portfolio in Q1 2026, its #40 holding.
  • Voya Financial Advisors first reported a position in Elevance Health in Q2 2015 and has held it in 43 quarters since.
  • Voya Financial Advisors's Elevance Health position peaked at $6.51M in Q1 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.